Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure
about
High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failureState of the Art: Newer biomarkers in heart failureSoluble ST2 Testing: A Promising Biomarker in the Management of Heart FailureRole of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trialPrognostic and diagnostic value of plasma soluble suppression of tumorigenicity-2 concentrations in acute respiratory distress syndrome.Prognostic impact of renal dysfunction does not differ according to the clinical profiles of patients: insight from the acute decompensated heart failure syndromes (ATTEND) registryThe prognostic value of plasma soluble ST2 in hospitalized Chinese patients with heart failure.Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: the BIOCRT study.Emerging biomarkers in heart failure and cardiac cachexiaSoluble ST2: a new and promising activity marker in ulcerative colitis.Relation of baseline plasma MMP-1 levels to long-term all-cause mortality in patients with known or suspected coronary artery disease referred for coronary angiography.Role of Soluble ST2 as a Prognostic Marker in Patients with Acute Heart Failure and Renal Insufficiency.Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction.Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction.Cardiovascular biomarkers in acute Kawasaki disease.Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals.Impact of Exhaled Breath Acetone in the Prognosis of Patients with Heart Failure with Reduced Ejection Fraction (HFrEF). One Year of Clinical Follow-upDistribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study.Soluble ST2 protein in chronic heart failure is independent of traditional factors.Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.Potential Markers in Cardiac Hypertrophy?Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.Soluble ST2 Levels and Left Ventricular Structure and Function in Patients With Metabolic Syndrome.Acute heart failure: patient characteristics and pathophysiology.Timing and duration of interventions in clinical trials for patients with hospitalized heart failure.Old and new biomarkers of heart failure.Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening.Soluble ST2 predicts elevated SBP in the communityST2: a novel biomarker for heart failure.Risk stratification and short-term prognosis in acute heart failure syndromes: a review of novel biomarkers.Novel biomarkers in acute heart failure.Novel biomarkers in human terminal heart failure and under mechanical circulatory support.Role of IL-33 in inflammation and disease.Diagnosing destabilized heart failure in the emergency setting: current and future biomarker tests.Experimental biomarkers in heart failure: an update.The Presage(®) ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2.ST2 as a cardiovascular risk biomarker: from the bench to the bedside.Heart failure biomarkers.Positioning of inflammatory biomarkers in the heart failure landscape.Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.
P2860
Q24610732-C0F85D3D-87FD-45A9-91D5-0ECA9C1B0433Q27027899-A0F181E0-C4E9-45C2-B208-FD2DDADF680DQ28066438-6832034B-1F46-40C7-BF47-C526CE589468Q28253329-FB6D959C-B1D4-4E96-BE0E-CBB3C9B6A429Q30409730-5DC8D1E9-4F0C-4C52-839D-D330DF1FA19CQ34149704-97B2EFEE-AA03-4975-85E0-31FB81BA48B3Q34408467-BC5D59C4-581F-4C4D-BBB2-9F32C9C2DC10Q34622450-900DE1FE-7920-431C-8050-21BF41AD1868Q34836097-5F908228-AC39-4B03-82DE-9B97BD84A84DQ34975712-7768586E-281F-41B0-B007-74CAEE417732Q35091397-6E185EE9-B288-4CD7-8692-EAA6B4D8A2AAQ35553684-C28E1C6A-6E7F-4F8C-BCE6-3F929FE9F1BAQ35555534-85A96917-DF78-425A-B7BB-F0886A754664Q35588992-E9591DE5-8EFD-4622-BB38-2C209BE2BE96Q35658781-3F8486A4-18FB-4850-9CB0-6DF203B47C48Q35930402-772B7355-CCAB-4623-B3F6-83FCB629CF25Q36234809-69C8F652-E5C8-4646-A3C8-5E1E02A5119BQ36569151-AA5325FE-197E-49F6-AA9C-021B36D7C8ABQ36686088-138EE11B-EA7E-40A9-8B82-E665BAD35E92Q36851584-14AA6A3D-694E-44C8-8E96-DD7E27A0E7DDQ37155198-7E3018A5-177E-4ACC-B262-416BB98568CEQ37200836-78FBE2EC-45B9-456E-A005-A686BBA08378Q37231505-2AE37AEC-0E5C-4D5C-9A57-235283AD8690Q37297364-910325AB-C2A5-4B50-B808-E2FB4B805DBAQ37354429-739B2E9C-6F4D-4269-9463-73D26AD59DE0Q37426212-8F75861F-EFB5-455A-AEBF-68A13C0B0E4BQ37457712-5396ADBD-1B24-4715-A5EC-51AA511E9B70Q37702150-5660C372-152D-468A-A256-8290F332219BQ37750852-AD150CB2-5F41-4B0E-BEE3-BC6C26AAB0DCQ37870921-5E4A4A78-8985-4C65-9F00-E17437FD1BF6Q37890908-266D1E6C-3210-46EB-A9E3-DF72F99A04A3Q37894731-C62374B3-4E60-4DF9-ACF9-0A0FF33B25B3Q37922810-E8EEE106-7A24-4CD4-8322-6232AA0E0788Q37970489-8342E0B8-9C60-4A20-B5BD-1C8AD1A882DBQ38055505-A6463748-6C64-45BD-BA7C-E06FB548342BQ38068933-6483182C-EBD2-41F3-94C4-71B0B7572553Q38096251-DDCF71A3-D7E1-45E5-8C2B-3F92556CDAC9Q38100647-F28A9579-8472-4AF6-BB6C-39A36E03F569Q38105986-E4108A21-3152-4018-8557-660690ECC48AQ38110226-AF0B7E39-20E3-4344-A660-AB84C0AA0869
P2860
Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Characteristics of the novel i ...... ients with acute heart failure
@ast
Characteristics of the novel i ...... ients with acute heart failure
@en
Characteristics of the novel i ...... ients with acute heart failure
@nl
type
label
Characteristics of the novel i ...... ients with acute heart failure
@ast
Characteristics of the novel i ...... ients with acute heart failure
@en
Characteristics of the novel i ...... ients with acute heart failure
@nl
prefLabel
Characteristics of the novel i ...... ients with acute heart failure
@ast
Characteristics of the novel i ...... ients with acute heart failure
@en
Characteristics of the novel i ...... ients with acute heart failure
@nl
P921
P3181
P1476
Characteristics of the novel i ...... ients with acute heart failure
@en
P2093
Shafiq U Rehman
Thomas Mueller
P304
P3181
P356
10.1016/J.JACC.2008.07.042
P407
P577
2008-10-28T00:00:00Z